Learn More
Medchemexpress LLC Vicriviroc maleate | 599179-03-0 | 99.9% | 649.70 | 100 MG

Supplier: Medchemexpress LLC HY17377100MG
Vicriviroc maleate is a potent, selective, oral bioavailable and CNS penetrated antagonist of CCR5, with a Ki of 2.5 nM. It also inhibits HIV-1 in PBMC cells, with IC90s of 3.3 nM (JrFL), 2.8 nM (ADA-M), 1.8 nM (301657), 4.9 nM (JV1083) and 10 nM (RU 570).
- Potent, selective, and oral bioavailable inhibitor of CCR5.
- Inhibits HIV-1 in PBMC cells.
- Demonstrates a mean IC50 and IC90 of 0.45 nM and 4 nM for a panel of HIV isolates.
- Exhibits good oral availability in rats and monkeys.
- No acute CNS or GI effects observed in rats.
- Shows weak activity against hERG (IC50, 5.8 μM).
- Inhibits chemotactic response to MIP-1α.
- Suppresses RANTES-induced signaling.
- Potently suppresses all tested viral isolates.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.